SWELLING

Adverse reaction reported in 161,473 FDA reports across 31 drugs.

161,473

Total Reports

Drugs Involved

Leflunomide

Most Reported Drug

Drugs Associated with SWELLING

Drugs where "SWELLING" was reported as an adverse event.

#	Drug	Reports	% of Total
1	Leflunomide	10,375	6.4%
2	Tocilizumab	10,349	6.4%
3	Abatacept	9,686	6.0%
4	Folic Acid	9,308	5.8%
5	Tofacitinib	9,272	5.7%
6	Rituximab	9,022	5.6%
7	Certolizumab Pegol	8,628	5.3%
8	Sulfasalazine	8,583	5.3%
9	Golimumab	8,550	5.3%
10	Cetirizine	8,037	5.0%
11	Alendronate	7,717	4.8%
12	Diclofenac	7,376	4.6%
13	Desoximetasone	7,132	4.4%
14	Cortisone	5,329	3.3%
15	Hydroxychloroquine	5,326	3.3%
16	Secukinumab	4,755	2.9%
17	Pseudoephedrine	4,528	2.8%
18	Ustekinumab	3,927	2.4%
19	Adalimumab-Adaz	3,627	2.2%
20	Cetiirizine	3,438	2.1%
21	Adalimumab-Aaty	3,353	2.1%
22	Adalimumab-Fkjp	3,346	2.1%
23	Sarilumab	2,657	1.6%
24	Chlorhexidine Gluconate	1,464	0.9%
25	Acetaminophen / Codeine	1,429	0.9%
26	Triamcinolone Acetonide	1,160	0.7%
27	Triamcinolone Acetonide Ointment Usp, 0.05%	1,124	0.7%
28	Gluconate	1,012	0.6%
29	Botulinum Toxin Type A	756	0.5%
30	Emicizumab	118	0.1%
31	Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	89	0.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused swelling. Always consult your healthcare provider.